Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
03.11.23
/
50%
€51.30
Target price
03.11.24
€94.07
Performance (%)
20.86%
Price
16:40
€61.50
Summary
This prediction is currently active. The prediction currently has a performance of 20.86%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 3.306% | 3.306% |
iShares Core DAX® | -1.042% | 2.220% |
iShares Nasdaq 100 | -1.361% | 3.207% |
iShares Nikkei 225® | -0.044% | -1.680% |
iShares S&P 500 | -0.480% | 2.165% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Cantor Fitzgerald from $98.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
24.04.24
24.04.24
€112.30
24.04.25
24.04.25
-10.22%
16:40
16:40
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€93.28
23.02.25
23.02.25
-5.09%
16:40
16:40
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
3.54%
16:40
16:40
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€80.23
29.03.24
29.03.24
22.14%
30.03.24
30.03.24